Petmed Express INC Form 4 insider transactions

Nina Capital Holdings, along with related parties, reports the acquisition of 50,000 shares of PetMed Express Inc. at an average price of $4.325 per share.

Nina Capital Holdings, along with related parties, reports the acquisition of 25,000 shares of PetMed Express Inc. at an average price of $4.82 per share.

Nina Capital Holdings, along with related parties, increased its holdings in PetMed Express Inc (PETS) through open market purchases.

PetMed Express CEO Sandra Campos acquired 146,772 shares of common stock and 146,772 performance share units through the company's 2024 Omnibus Incentive Plan.

Jacqueline Paula Smith, Vice President of People at PetMed Express, was granted 8,000 restricted stock units (RSUs) on January 15, 2025, which vest over three years.

Nina Capital Holdings, along with related parties, reports the acquisition of 25,000 shares of PetMed Express Inc. at an average price of $4.975 per share, increasing their total holdings to 2,175,000 shares.

Nina Capital Holdings, along with related parties, acquired 32,000 shares of PetMed Express at an average price of $5.655, increasing their total holdings to 2,150,000 shares.

Nina Capital Holdings and related parties, including Moises Tache Galante and Stephannie Matz Zyman, have purchased 40,000 shares of PetMed Express Inc. common stock at an average price of $5.55.

Leslie C.G. Campbell, a PetMed Express Inc. insider, has purchased a total of 60,000 shares of common stock through open market transactions across multiple days.

Nina Capital Holdings, along with related parties, reports acquiring 12,500 shares of PetMed Express Inc at $3.34 per share, increasing their total holdings to 2,078,000 shares.

PetMed Express CFO Robyn D'Elia reports the acquisition of 250,000 restricted stock units (RSUs) granted under the company's 2024 Inducement Incentive Plan.

Jacqueline Paula Smith, Vice President of People at PetMed Express, Inc., sold 601 shares of common stock at a price of $3.19 per share on August 15, 2024.

Gian Fulgoni, a director of PetMed Express, acquired 7,500 shares of common stock on August 8, 2024, through the grant of restricted stock units.

Director Leah Solivan reports acquisition of restricted stock units and disposal of common stock.

Director Justin L. Mennen reports acquisition of restricted stock units and disposal of common stock in PetMed Express, Inc.

Director Diana Purcel reports acquisition of 7,500 restricted stock units in PetMed Express, Inc.

Leslie C.G. Campbell, a director of PetMed Express, reports acquiring 7,500 shares of common stock and disposing of 55,000 shares.

Director Leah Solivan reports acquisition of 943 restricted stock units in PetMed Express, Inc.

Director Justin L. Mennen acquired 1,373 restricted stock units of PetMed Express, Inc. on June 3, 2024, which will vest on June 3, 2025, subject to continued service.

Christine Chambers, CFO of PetMed Express, forfeited shares and performance share units as part of a Transition and Separation Agreement dated May 31, 2024.

Christine Chambers, CFO of PetMed Express, reports the acquisition of 74,850 shares of common stock through restricted stock units and the disposal of 106,488 shares.

Former PetMed Express officer Mathew N. Hulett forfeited 510,000 shares of common stock on April 29, 2024, due to cessation of employment.

Sandra Campos, CEO and President of PetMed Express, reports acquisition of restricted stock units.